Expert Opinion on Drug Discovery, Volume 17, Issue 12 (2022)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Drug Discovery, Volume 17, Issue 12 (2022)

See all volumes and issues
Vol 19, 2024 Vol 18, 2023 Volume 17, 2022 Vol 16, 2021 Vol 15, 2020 Vol 14, 2019 Vol 13, 2018 Vol 12, 2017 Vol 11, 2016 Vol 10, 2015 Vol 9, 2014 Vol 8, 2013 Vol 7, 2012 Vol 6, 2011 Vol 5, 2010 Vol 4, 2009 Vol 3, 2008 Vol 2, 2007 Vol 1, 2006
Download citations Download PDFs Download issue

Editorial

Editorial
The potential of natural sources for pancreatic lipase inhibitors: a solution of the obesity crisis?
Xu-Dong Hou, Xiao-Ya Qin, Jie Hou, Hui Tang & Guang-Bo Ge
Pages: 1295-1298
Published online: 12 Dec 2022
First Page PreviewforThe potential of natural sources for pancreatic lipase inhibitors: a solution of the obesity crisis? | Full Text | References | PDF (307.7 KB) | EPUB
  • 2099 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access

Drug Discovery Case History

Article
The preclinical discovery and development of molnupiravir for the treatment of SARS-CoV-2 (COVID-19)
Pasquale Pagliano, Carmine Sellitto, Tiziana Ascione, Giuliana Scarpati, Veronica Folliero, Ornella Piazza, Gianluigi Franci, Amelia Filippelli & Valeria Conti
Pages: 1299-1311
Published online: 12 Dec 2022
AbstractforThe preclinical discovery and development of molnupiravir for the treatment of SARS-CoV-2 (COVID-19) | Full Text | References | PDF (2.5 MB) | EPUB
  • 265 Views
  • 2 CrossRef citations
  • 0Altmetric

Review

Review
Approaches for the discovery of drugs that target K Na 1.1 channels in KCNT1-associated epilepsy
Barbara Miziak & Stanisław J Czuczwar
Pages: 1313-1328
Published online: 24 Nov 2022
AbstractforApproaches for the discovery of drugs that target K Na 1.1 channels in KCNT1-associated epilepsy | Full Text | References | PDF (656.9 KB) | EPUB
  • 185 Views
  • 0 CrossRef citations
  • 0Altmetric
Review
The current progress in the use of boron as a platform for novel antiviral drug design
Shuo Wang, Yujie Ren, Zhao Wang, Xiangyi Jiang, Shujing Xu, Xujie Zhang, Shujie Zhao, Waleed A Zalloum, Xinyong Liu & Peng Zhan
Pages: 1329-1340
Published online: 05 Dec 2022
AbstractforThe current progress in the use of boron as a platform for novel antiviral drug design | Full Text | References | PDF (3.7 MB) | EPUB
  • 242 Views
  • 0 CrossRef citations
  • 0Altmetric
Review
Approaches for development of LAG-3 inhibitors and the promise they hold as anticancer agents
Martin Perez-Santos, Maricruz Anaya-Ruiz, Luis Villafaña-Diaz & Gabriela Sánchez Esgua
Pages: 1341-1355
Published online: 24 Nov 2022
AbstractforApproaches for development of LAG-3 inhibitors and the promise they hold as anticancer agents | Full Text | References | PDF (336.2 KB) | EPUB
  • 176 Views
  • 0 CrossRef citations
  • 0Altmetric
Review
Benzofuran as a promising scaffold for the synthesis of novel antimicrobial agents
Ashraf A. Abbas & Kamal M. Dawood
Pages: 1357-1376
Published online: 18 Dec 2022
AbstractforBenzofuran as a promising scaffold for the synthesis of novel antimicrobial agents | Full Text | References | PDF (2 MB) | EPUB
  • 113 Views
  • 2 CrossRef citations
  • 0Altmetric
Review
Lessons learned from the discovery and development of the sesquiterpene lactones in cancer therapy and prevention
Israa A. Cheikh, Chirine El-Baba, Ali Youssef, Najat A. Saliba, Akram Ghantous & Nadine Darwiche
Pages: 1377-1405
Published online: 05 Dec 2022
AbstractforLessons learned from the discovery and development of the sesquiterpene lactones in cancer therapy and prevention | Full Text | References | PDF (2.4 MB) | EPUB | Supplemental
  • 243 Views
  • 0 CrossRef citations
  • 0Altmetric
Review
Tachyplesin I and its derivatives: A pharmaco-chemical perspective on their antimicrobial and antitumor potential
Shengxin Lu, Jiayi Lin, Jinmei Jin, Lijun Zhang, Yingyun Guan, Hongzhuan Chen, Ye Wu, Weidong Zhang & Xin Luan
Pages: 1407-1423
Published online: 27 Dec 2022
AbstractforTachyplesin I and its derivatives: A pharmaco-chemical perspective on their antimicrobial and antitumor potential | Full Text | References | PDF (4.7 MB) | EPUB
  • 218 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Research

Article
Machine learning-based prediction of drug approvals using molecular, physicochemical, clinical trial, and patent-related features
Fulya Ciray & Tunca Doğan
Pages: 1425-1441
Published online: 13 Dec 2022
AbstractforMachine learning-based prediction of drug approvals using molecular, physicochemical, clinical trial, and patent-related features | Full Text | References | PDF (8.2 MB) | EPUB | Supplemental
  • 295 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

The value of protein allostery in rational anticancer drug design: an update
Ruth Nussinov et al.
Review Article | Published online: 28 Jul 2024
Open Access
Complementary strategies to be used in conjunction with animal models for multiple sclerosis drug discovery: adapting preclinical validation of drug candidates to the need of remyelinating strategies
Imane Charmarke-Askar et al.
Review Article | Published online: 22 Jul 2024
What impact does tautomerism have on drug discovery and development?
Devendra K. Dhaked et al.
Editorial | Published online: 16 Jul 2024
Free Access
Polypharmacology prediction: the long road toward comprehensively anticipating small-molecule selectivity to de-risk drug discovery
Leticia Manen-Freixa et al.
Review Article | Published online: 14 Jul 2024
View all latest articles